prozapalne

Prozapalne is a term used in medical literature, particularly in Polish, to describe substances, signals, or processes that promote inflammatory responses in tissues. In English contexts, the term is commonly translated as proinflammatory.

Pro-inflammatory mediators include cytokines such as TNF-α, IL-1β, and IL-6; lipid mediators like prostaglandins (for example, PGE2); chemokines; and innate immune receptors that activate pathways such as NF-κB. These mediators trigger fever, vascular changes, and the recruitment and activation of leukocytes, enabling host defense and tissue repair. However, excessive or chronic prozapalne signaling contributes to inflammatory diseases when immune regulation fails.

Conditions associated with heightened prozapalne activity include rheumatoid arthritis, inflammatory bowel disease, psoriasis, obesity-related inflammation, and sepsis in severe cases. Clinical assessment uses biomarkers such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), alongside cytokine profiles and imaging in some contexts.

Treatment aims to reduce harmful prozapalne signaling using nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and biologic agents targeting TNF, IL-1, or IL-6, as well as lifestyle interventions to modulate systemic inflammation. The concept underscores the balance between protective inflammation and its potential contribution to chronic disease when regulation is disrupted.